Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujian Pacific Pharmaceutical is a Chinese pharmaceutical manufacturing company established in 1992 and based in Quanzhou, Fujian Province. The company specializes in the production and research and development of chemical drug preparations and traditional Chinese patent medicines, holding dozens of national drug approvals. Its core product portfolio includes widely distributed over-the-counter (OTC) and clinical products such as Ibuprofen sustained-release capsules, Triamcinolone Acetonide and Econazole Nitrate cream, Fengyoujing (medicated oil), and Wujigao. Fujian Pacific Pharmaceutical operates multiple GMP-certified production workshops capable of manufacturing tablets, capsules, creams, gels, liniments, and large-volume injections. Additionally, the company serves as a long-term manufacturing partner and supplier for leading Chinese pharmaceutical brands, including Renhe Pharmacy, Xiu Zheng Pharmaceutical, and Kuihua Pharmaceutical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fujian Pacific Pharmaceutical.